Common Equity: The sum of all common equity items.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Common Equity of $147.50M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-20.55M |
|
-- |
|
-- |
|
$21.97M |
|
$-21.97M |
|
$1.41M |
|
$-20.55M |
|
$-20.55M |
|
$-20.55M |
|
$-20.55M |
|
$-20.55M |
|
$-20.55M |
|
$-21.97M |
|
$-22.61M |
|
13.32M |
|
13.32M |
|
$-1.17 |
|
$-1.17 |
|
| Balance Sheet Financials | |
$166.95M |
|
$0.16M |
|
$1.24M |
|
$168.19M |
|
$20.69M |
|
-- |
|
-- |
|
$20.69M |
|
|
Common Equity |
$147.50M |
$147.50M |
|
$147.50M |
|
17.61M |
|
| Cash Flow Statement Financials | |
$-64.49M |
|
$-1.64M |
|
$77.43M |
|
$17.87M |
|
$29.16M |
|
$11.29M |
|
$6.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-64.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.94% |
|
-13.94% |
|
-12.22% |
|
-13.94% |
|
$8.38 |
|
$-4.84 |
|
$-4.84 |
|